A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Blood

• Publication date

  1997-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V89.12.4282PMID 9192750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs.

  1996cited by this paper
• The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.

  1996cited by this paper
• Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines.

  1996cited by this paper
• A retrovirus carrying the promyelocyte‐retinoic acid receptor PML‐RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias.

  1996cited by this paper
• Differentiation therapy of acute promyelocytic leukemia.

  1996cited by this paper
• Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.

  1996cited by this paper
• Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.

  1996cited by this paper
• Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.

  1995cited by this paper
• Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid

  1995cited by this paper
• Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.

  1995cited by this paper
• Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

  1995cited by this paper
• All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

  1995cited by this paper
• Phosphorylation of the retinoic acid receptor-alpha by protein kinase A.

  1995cited by this paper
• 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.

  1995cited by this paper
• Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.

  1995cited by this paper
• Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.

  1994cited by this paper
• Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha.

  1994cited by this paper
• A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.

  1994cited by this paper
• Retinoic Acid-induced Expression of CD38 Antigen in Myeloid Cells Is Mediated through Retinoic Acid Receptor-α

  1994cited by this paper
• Acute promyelocytic leukemia.

  1993cited by this paper
• Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein.

  1993cited by this paper
• PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.

  1993cited by this paper
• Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid.

  1993cited by this paper
• Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications.

  1993cited by this paper
• The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

  1993cited by this paper
• The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells.

  1993cited by this paper
• Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.

  1992cited by this paper
• A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features.

  1992cited by this paper
• Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity.

  1992cited by this paper
• Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients.

  1992cited by this paper
• Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.

  1992cited by this paper
• Retinoids, retinoid-responsive genes, cell differentiation, and cancer.

  1992cited by this paper
• Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.

  1992cited by this paper
• Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

  1991cited by this paper
• Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.

  1991cited by this paper
• The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

  1991cited by this paper
• A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.

  1991cited by this paper
• NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).

  1991cited by this paper
• All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

  1990cited by this paper
• A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell

  1990cited by this paper
• Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene

  1990cited by this paper
• Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene.

  1990cited by this paper
• Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells.

  1989cited by this paper
• A novel rapid assay for chloramphenicol acetyltransferase gene expression

  1987cited by this paper
• Cloning of the beta subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family.

  1987cited by this paper
• Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

  1984cited by this paper
• Identification of two distinct regulatory regions adjacent to the human β-interferon gene

  1983cited by this paper
• Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

  1983cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells.

  2023cites this paper
• A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®

  2022cites this paper
• Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells

  2020cites this paper
• Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies

  2019cites this paper
• A Novel Therapeutic Approach in Acute Promyelocytic Leukemia with All-trans retinoic Acid and Cyclin-dependent Kinase Inhibitors

  2018cites this paper
• Relapsed Acute Promyelocytic Leukemia Lacks “Classic” Leukemic Promyelocyte Morphology and Can Create Diagnostic Challenges

  2017cites this paper
• The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia

  2017cites this paper
• Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress

  2017cites this paper
• PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL

  2016cites this paper
• NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

  2016cites this paper
• Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?

  2015cites this paper
• Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells

  2015cites this paper
• Overcoming The Differentiation Block: Mechanisms Of Retinoic Acid-Induced Differentiation, Resistance, And Lineage Selection In Myeloid Leukemia Progenitor Cells

  2015influential citation
• Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.

  2015cites this paper
• Retinoic acid receptors: from molecular mechanisms to cancer therapy.

  2015cites this paper
• Triple A therapy: the molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide.

  2014cites this paper
• Contemporary Treatment of APL

  2014cites this paper
• Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines

  2014cites this paper
• Tamibarotene for the treatment of acute promyelocytic leukemia

  2014cites this paper
• Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts

  2014cites this paper
• Analysis of gene profiles involved in the enhancement of all-trans retinoic acid-induced HL-60 cell differentiation by sesquiterpene lactones identifies asparagine synthetase as a novel target for differentiation-inducing therapy.

  2014cites this paper
• Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392.

  2014cites this paper
• Efficacy and resistance of molecularly targeted therapy for myeloid malignancies Mechanisms of action and resistance to all-trans retinoic acid ( ATRA ) and arsenic trioxide ( As 2 O 3 ) in acute promyelocytic leukemia

  2013cites this paper
• Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia

  2013cites this paper
• In vitro inhibition of mumps virus by retinoids

  2013cites this paper
• The Src-Family Kinase Inhibitor PP2 Rescues Inducible Differentiation Events in Emergent Retinoic Acid-Resistant Myeloblastic Leukemia Cells

  2013cites this paper
• Genes Reprogramming During ATRA-induced Differentiation of Acute Promyelocytic Leukemia Cells

  2013cites this paper
• protein, with retinoic acid receptor and STAT3 signaling pathways , a novel acute promyelocytic leukemia fusion α Interactions of STAT5b-RAR

  2013cites this paper
• Effects of PPARγ Ligands on Leukemia

  2012cites this paper
• Altered nuclear cofactor switching in retinoic‐resistant variants of the PML‐RARα oncoprotein of acute promyelocytic leukemia

  2012cites this paper
• Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.

  2011cites this paper
• Acute Promyelocytic Leukemia: A Model Disease for Targeted Cancer Therapy

  2011cites this paper
• Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells

  2011cites this paper
• The role of aldehyde dehydrogenase (ALDH) isoform 1A3 in the pathogenesis of human acute myeloid leukemia (AML)

  2011cites this paper
• A Case of Acute Promyelocytic Leukemia with a De novo t(11;19) Chromosomal Translocation

  2011cites this paper
• RIG-I Is Required for the Inhibition of Measles Virus by Retinoids

  2011cites this paper
• Targeting PKCδ-mediated topoisomerase IIβ overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line

  2010cites this paper
• Rational targeting in acute promyelocytic leukemia.

  2010cites this paper
• cells synergistic differentiation induction with ATRA in myeloid leukemic Pharicin B stabilizes retinoic acid receptor-{alpha} and presents

  2010cites this paper
• Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells.

  2010cites this paper
• PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.

  2010cites this paper
• Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.

  2009influential citation
• Resistance to Differentiation Therapy

  2009cites this paper
• Drug resistance in cancer cells

  2009cites this paper
• Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells

  2008cites this paper
• Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways.

  2008cites this paper
• Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.

  2008cites this paper
• Emerging role for microRNAs in acute promyelocytic leukemia.

  2007cites this paper
• Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.

  2007cites this paper
• Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein

  2007cites this paper
• RXR is an essential component of the oncogenic PML/RARA complex in vivo.

  2007cites this paper
• Recruitment of RXR by homotetrameric RARalpha fusion proteins is essential for transformation.

  2007cites this paper
• Tamibarotene.

  2007cites this paper
• Mouse models of acute promyelocytic leukemia.

  2007cites this paper
• PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL

  2007cites this paper
• Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.

  2006cites this paper
• Btg2 Enhances Retinoic Acid-Induced Differentiation by Modulating Histone H4 Methylation and Acetylation

  2006cites this paper
• Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure

  2006cites this paper
• CHAPTER 27 – Differentiation Induction in Leukemia and Lymphoma

  2006cites this paper
• Role of PML/RARα in the pathogenesis of APL

  2006cites this paper
• In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemia

  2006cites this paper
• Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin‐dependent kinase‐activating kinase binding and phosphorylation of PML/RAR

  2006cites this paper
• PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.

  2006cites this paper
• PML-RARα and AML1–ETO translocations are rarely associated with methylation of the RARβ2 promoter

  2006cites this paper
• Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha.

  2006cites this paper
• Retinoic Acid in Acute Promyelocytic Leukemia Cells Trans Protein II and Lack of Correlation with Sensitivity to All-Constitutive Expression of Cellular Retinoic Acid Binding Updated

  2006cites this paper
• A sumoylation site in PML/RARA is essential for leukemic transformation.

  2005cites this paper
• Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.

  2005cites this paper
• A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

  2005cites this paper
• Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo

  2005cites this paper
• Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells

  2005cites this paper
• Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells

  2005cites this paper
• Induction of murine leukemia and lymphoma by dominant negative retinoic acid receptor α

  2005cites this paper
• Treatment concepts of acute promyelocytic leukemia.

  2005cites this paper
• How patients have benefited from mouse models of acute promyelocytic leukaemia

  2005cites this paper
• The PML-RARα Fusion Protein and Targeted Therapy for Acute Promyelocytic Leukemia

  2004cites this paper
• The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.

  2004cites this paper
• Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.

  2004cites this paper
• Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells.

  2004cites this paper
• PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation

  2004cites this paper
• The Retinoids and Cancer Chemoprevention

  2004cites this paper
• Retinoic Acid in Myeloid Differentiation and Acute Promyelocytic Leukemia (APL)

  2003cites this paper
• Brief Definitive Report

  2003cites this paper
• Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.

  2003cites this paper
• A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.

  2003cites this paper
• Retinoids in cancer therapy and chemoprevention: promise meets resistance

  2003cites this paper
• The cleavage product ΔPML–RARα contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells

  2003influential citation
• The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease.

  2003cites this paper
• Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors β and γ Interferes with Corepressor Recruitment and Prevents Transcriptional Repression

  2003cites this paper
• Retinoic acid metabolism and mechanism of action: a review.

  2003cites this paper
• Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines

  2003cites this paper
• Retinoids in myelopoiesis.

  2003cites this paper
• The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.

  2003cites this paper
• The emergence of resistance to targeted cancer therapeutics.

  2002cites this paper
• Molecular cytogenetics of the acute promyelocytic leukemia‐derived cell line NB4 and of four all‐trans retinoic acid–resistant subclones

  2002cites this paper
• A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation

  2002cites this paper
• Retinoic acid resistance in acute promyelocytic leukemia

  2002cites this paper
• Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.

  2002cites this paper
• Advances in the Treatment of Relapsed Acute Promyelocytic Leukemia

  2002cites this paper
• Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.

  2002cites this paper